Stocktoria

ADIAL PHARMACEUTICALS, INC. ADIL

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-07-27

ADIAL PHARMACEUTICALS, INC. statistics & valuation

Market cap$5.6M
P / B1.1×
Return on equity-151.2%
Return on capital-147.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
201720182019202020212022202320242025
Operating margin (%)
201720182019202020212022202320242025
Return on equity (%)
-261.90% -120.30% -273.30% -553.70% -388.60% -125.50% -324.40% -151.20% 201720182019202020212022202320242025
Shares outstanding
3.3M 6.9M 10.4M 14.4M 20.9M 25.0M 1.7M 258826 1.1M 201720182019202020212022202320242025
Net debt ($)
201720182019202020212022202320242025
Share buybacks ($)
201720182019202020212022202320242025
Return on assets (%)
-3298.40% -247.50% -111.90% -198.40% -259.80% -222.10% -108.20% -261.60% -119.50% 201720182019202020212022202320242025
Free cash flow margin (%)
201720182019202020212022202320242025
Debt / equity (×)
201720182019202020212022202320242025
EPS ($)
-$1.04 -$12.71 -$3.60 -$68.01 -$11.93 201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Return on assets-119.5%-261.6%-108.2%-222.1%-259.8%-198.4%-111.9%-247.5%-3298.4%
Return on equity-151.2%-324.4%-125.5%-388.6%-553.7%-273.3%-120.3%-261.9%114.2%
Current ratio4.424.164.902.672.373.4114.2418.190.03

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.